Search
Displaying 791–800 of 898 results for “vision connection”
-
The Retinal Degeneration Fund invests in a $78M Series B for Perceive Biotherapeutics
In the PressThe investment supports the clinical development of two novel programs, both with the aim of being protective against vision loss.
-
Opus Genetics Acquires Rights to Gene Therapies for BEST1 and RP (RHO)
Research NewsThe company plans to seek clinical trial authorization for the BEST1 gene therapy during the second half of 2023
-
Your Dollar Makes a Difference
Foundation NewsAt the Foundation Fighting Blindness, a dollar is more than just a dollar – it’s a path to transforming lives. But just where does your donation go?
-
Eye on the Cure Podcast | Episode 36: Sue Bramhall
Eye on the CureDecember 2, 2022. Host Ben Shaberman interviews Sue Bramhall.
-
Foundation News
Uni-Rare Study will improve clinical understanding of more IRDs and boost development of potential therapies.
-
Eye on the Cure Podcast | Episode 34: LambdaVision
Eye on the CureNovember 4, 2022. Ben Shaberman talks with LambdaVision’s Nicole Wagner, PhD, and Jordan Greco, PhD.
-
PRPH2 and Associated Retinal Diseases Workshop 2023
Save the Date! The PRPH2 and AAssociated Retinal Diseases Workshop will be on March 29-31, 2023, at the Hilton La Jolla Torrey Pines in San Diego, CA.
-
My name is Terry Super. As a Professional Engineer, my career was defined by technical and left-brained stuff. Today, I’m semi-retired and have been relaxing by doing some creative and right-brained stuff - oil painting.
-
Opus Genetics Appoints Jennifer Hunt Chief Development Officer
In the PressBiopharma clinical development veteran to propel Opus’ AAV-based gene therapies for inherited retinal diseases toward patients.
-
Lighting The Way. The book celebrating 50 years of driving the research for blinding diseases.
.png)
.png)
